The Galectin 3 pipeline drugs market research report outlays comprehensive information on the Galectin 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Galectin 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Respiratory, Gastrointestinal, and Cardiovascular which include the indications Metastatic Melanoma, Recurrent Head And Neck Squamous Cell Carcinoma, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Arrhythmias, and Atrial Fibrillation. It also reviews key players involved in Galectin 3 targeted therapeutics development with respective active and dormant or discontinued products.
The Galectin 3 pipeline targets constitutes close to 12 molecules. Out of which, approximately 11 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Preclinical, and Discovery stages are 1, 2, 7, and 1 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Galectin 3 overview
Galectin-3 is a protein encoded by the LGALS3 gene. It mediates with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration. It acts as a pre-mRNA splicing factor. It is involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells.
For a complete picture of Galectin 3’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.